KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Clorox (CLX) Research & Development (2016 - 2025)

Clorox has reported Research & Development over the past 17 years, most recently at $29.0 million for Q4 2025.

  • Quarterly results put Research & Development at $29.0 million for Q4 2025, down 6.45% from a year ago — trailing twelve months through Dec 2025 was $116.0 million (down 8.66% YoY), and the annual figure for FY2025 was $121.0 million, down 3.97%.
  • Research & Development for Q4 2025 was $29.0 million at Clorox, up from $28.0 million in the prior quarter.
  • Over the last five years, Research & Development for CLX hit a ceiling of $45.0 million in Q2 2021 and a floor of $27.0 million in Q1 2025.
  • Median Research & Development over the past 5 years was $32.0 million (2021), compared with a mean of $32.6 million.
  • Biggest five-year swings in Research & Development: dropped 24.44% in 2022 and later increased 12.9% in 2023.
  • Clorox's Research & Development stood at $34.0 million in 2021, then decreased by 2.94% to $33.0 million in 2022, then decreased by 3.03% to $32.0 million in 2023, then decreased by 3.12% to $31.0 million in 2024, then fell by 6.45% to $29.0 million in 2025.
  • The last three reported values for Research & Development were $29.0 million (Q4 2025), $28.0 million (Q3 2025), and $32.0 million (Q2 2025) per Business Quant data.